Suprascapular nerve block with versus without ultrasound-guided T2 erector spinae plane block for chronic shoulder pain: A retrospective comparative study

Suprascapular nerve block (SSNB) is widely used for chronic shoulder pain but may provide suboptimal analgesia because of incomplete coverage of the shoulder's sensory innervation. High thoracic (T2) erector spinae plane block (ESPB) provides broad craniocaudal spread and may complement SSNB. This study evaluated whether SSNB with T2 ESPB was associated with improved clinical outcomes compared with SSNB without T2 ESPB in patients with chronic, conservative-refractory shoulder pain. This retrospective comparative study included 84 adult patients with chronic shoulder pain lasting at least 3 months despite conservative treatment at a tertiary academic hospital. Patients underwent ultrasound-guided SSNB without T2 ESPB (n = 57) or SSNB with T2 ESPB (n = 27). The primary outcome was the proportion of responders, defined as achieving a ≥30% reduction in numeric rating scale (NRS) pain score at 4 weeks. Secondary outcomes included NRS pain score at 4 weeks, patient global impression of change (PGIC), and procedure-related adverse events. Multivariable logistic regression was performed to adjust for potential confounders. At 4 weeks, the responder rate was higher in the SSNB with T2 ESPB group than in the SSNB without T2 ESPB group (59.3% vs 17.5%, P < .001). The combined group also had a lower mean NRS pain score (3.9 ± 2.8 vs 5.2 ± 2.6, P = .049) and higher PGIC scores (median [IQR], 4 [4-5] vs 4 [3-4]; P = .010). In multivariable analysis, SSNB with T2 ESPB remained associated with a positive response (OR 5.931, 95% confidence interval: 2.01-17.50, P = .001). No procedure-related adverse events were identified. SSNB with T2 ESPB was associated with better short-term clinical outcomes than SSNB alone in patients with chronic shoulder pain. Prospective randomized, dose-matched studies are needed to confirm these findings and clarify the specific contribution of T2 ESPB.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051607
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Suprascapular nerve block with versus without ultrasound-guided T2 erector spinae plane block for chronic shoulder pain: A retrospective comparative study

Seungpyo Nam, Jeong-Soo Kim, Seungcheol Yu, Kaehong Lee et al.
Medicine
Anesthesia and Pain Management
article

Suprascapular nerve block with versus without ultrasound-guided T2 erector spinae plane block for chronic shoulder pain: A retrospective comparative study

Seungpyo Nam, Jeong-Soo Kim, Seungcheol Yu, Kaehong Lee, Ji Il Kim
article en

Abstract

Suprascapular nerve block (SSNB) is widely used for chronic shoulder pain but may provide suboptimal analgesia because of incomplete coverage of the shoulder's sensory innervation. High thoracic (T2) erector spinae plane block (ESPB) provides broad craniocaudal spread and may complement SSNB. This study evaluated whether SSNB with T2 ESPB was associated with improved clinical outcomes compared with SSNB without T2 ESPB in patients with chronic, conservative-refractory shoulder pain. This retrospective comparative study included 84 adult patients with chronic shoulder pain lasting at least 3 months despite conservative treatment at a tertiary academic hospital. Patients underwent ultrasound-guided SSNB without T2 ESPB (n = 57) or SSNB with T2 ESPB (n = 27). The primary outcome was the proportion of responders, defined as achieving a ≥30% reduction in numeric rating scale (NRS) pain score at 4 weeks. Secondary outcomes included NRS pain score at 4 weeks, patient global impression of change (PGIC), and procedure-related adverse events. Multivariable logistic regression was performed to adjust for potential confounders. At 4 weeks, the responder rate was higher in the SSNB with T2 ESPB group than in the SSNB without T2 ESPB group (59.3% vs 17.5%, P < .001). The combined group also had a lower mean NRS pain score (3.9 ± 2.8 vs 5.2 ± 2.6, P = .049) and higher PGIC scores (median [IQR], 4 [4-5] vs 4 [3-4]; P = .010). In multivariable analysis, SSNB with T2 ESPB remained associated with a positive response (OR 5.931, 95% confidence interval: 2.01-17.50, P = .001). No procedure-related adverse events were identified. SSNB with T2 ESPB was associated with better short-term clinical outcomes than SSNB alone in patients with chronic shoulder pain. Prospective randomized, dose-matched studies are needed to confirm these findings and clarify the specific contribution of T2 ESPB.

MedicineVol. 105(46)
Seoul National University (KR), Seoul National University Hospital (KR)
Good health and well-being
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon